Mirae Asset Global ETFs Holdings’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.93M Sell
46,169
-51,467
-53% -$5.6M 0.01% 778
2026
Q1
$9.02M Buy
97,636
+3,760
+4% +$378K 0.01% 664
2025
Q4
$9.59M Sell
93,876
-6,228
-6% -$557K 0.01% 650
2025
Q3
$6.25M Sell
100,104
-11,341
-10% -$617K 0.01% 747
2025
Q2
$5.8M Buy
111,445
+40,209
+56% +$1.8M 0.01% 719
2025
Q1
$3.03M Buy
71,236
+4,056
+6% +$175K 0.01% 926
2024
Q4
$2.05M Buy
67,180
+2,562
+4% +$72.1K ﹤0.01% 1116
2024
Q3
$1.48M Buy
64,618
+7,673
+13% +$217K ﹤0.01% 1314
2024
Q2
$1.64M Buy
+56,945
New +$1.33M ﹤0.01% 1173

Other funds holding GH

Mirae Asset Global ETFs Holdings's GH Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Guardant Health (GH) stake by 53% in Q2 2026, selling an estimated $5.6M and leaving 46,169 shares worth $6.93M. The position accounts for 0.01% of the portfolio, ranked #778.

Mirae Asset Global ETFs Holdings first reported a position in GH in Q2 2024 and has held it in 9 quarters since. The position peaked at $9.59M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 46,169 shares of Guardant Health worth $6.93M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 51,467 Guardant Health shares in Q2 2026, an estimated $5.6M.
  • Guardant Health made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #778 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Guardant Health in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Guardant Health position peaked at $9.59M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.